Logo image of ZBIO

ZENAS BIOPHARMA INC (ZBIO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ZBIO - US98937L1052 - Common Stock

39.38 USD
+1.27 (+3.33%)
Last: 12/5/2025, 8:00:02 PM
39.98 USD
+0.6 (+1.52%)
After Hours: 12/5/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ZBIO revenue by date.ZBIO revenue by date.
50M5M
-90.00%
42.5M
750.00%

-100.00%
51.911M140.89M
171.41%
281.32M
99.67%
480.99M
70.98%
682.41M
41.88%
912.94M
33.78%
EBITDA
YoY % growth
ZBIO ebitda by date.ZBIO ebitda by date.
-75.121M-27.034M
64.01%
-163.751M
-505.72%
-207.551M
-26.75%
-233.479M
-12.49%
-268.47M
-14.99%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ZBIO ebit by date.ZBIO ebit by date.
-75.199M-27.147M
63.90%
-163.888M
-503.71%
-185.282M
-13.05%
-235.379M
-27.04%
-267.838M
-13.79%
-267.556M
0.11%
-196.911M
26.40%
-58.532M
70.27%
27.605M
147.16%
343.28M
1,143.54%
Operating Margin
ZBIO operating margin by date.ZBIO operating margin by date.
N/A-54.29%-3,277.76%-435.96%N/A-515.96%-189.90%-70.00%-12.17%4.05%37.60%
EPS
YoY % growth
ZBIO eps by date.ZBIO eps by date.
N/AN/AN/A-3.77
49.50%
-4.32
-14.46%
-4.08
5.59%
-3.14
22.93%
-2.39
24.03%
-1.02
57.26%
0.58
157.00%
2.36
305.26%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.48
87.93%
-1.15
-43.69%
-1.20
4.08%
-1.21
0.51%
-1.09
-126.59%
-1.18
-2.93%
-1.13
5.66%
-0.97
20.25%
-0.93
14.91%
Revenue
Q2Q % growth
64.6M
1,192.00%

-100.00%
2.193M
-96.61%
1.624M5.328M10.779M18.297M
734.34%
EBITDA
Q2Q % growth
-55.102M
0.69%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-20.17M
63.74%
-57.324M
-53.56%
-62.22M
-12.79%
-67.728M
-42.35%
-60.384M
-199.38%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.22
75.70%
-1.07-0.15-14.17%
Q2 2025
Q2Q % growth
-1.25 -1.07-0.18-16.71%
Q1 2025
Q2Q % growth
-0.80 -1.130.3329.34%
Q4 2024
Q2Q % growth
-3.99 -1.02-2.97-290.79%
Q3 2024
Q2Q % growth
-5.02 -9.514.4947.24%
ZBIO Yearly EPS VS EstimatesZBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
10.2M-10.2M-100.00%
Q2 2025
Q2Q % growth
1.275M-1.275M-100.00%
Q1 2025
Q2Q % growth
10M 1.7M8.3M488.24%
Q3 2024
Q2Q % growth

-100.00%
%
ZBIO Yearly Revenue VS EstimatesZBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS44.96% 59.86% 2.8% 17.33%
Revenue63.44% N/A 16.28% 316.67%